Cilostazol 100mg Tablet in PCD Pharma Franchise in Hyderabad

Cilostazol 100mg Tablet in Pharmaceutical Manufacturing Company in Ahmedabad

Cilostazol 100mg Tablet in Neurovascular Pharma Franchise in Bhopal

Cilostazol 100mg Tablet in Pharma Distributors & Suppliers in Kolkata

Cilostazol 100mg Tablet in Pharma Export Company in Mumbai
Cilostazol 100mg Tablet in Pharma Franchise Opportunity in Bengaluru

Home/Products /cilostazol-100-mg-tablet

Cilospace 100 Tablet

Composition : Cilostazol 100mg Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹329/-

Cilospace 100 Tablet contains Cilostazol 100mg, a selective phosphodiesterase III inhibitor with antiplatelet and vasodilatory properties. It is primarily used to manage symptoms of intermittent claudication caused by peripheral arterial disease (PAD). Cilostazol works by inhibiting platelet aggregation and promoting vasodilation in the blood vessels, thereby enhancing blood flow, especially in the lower limbs. This improves oxygen delivery to muscles and helps patients walk longer distances without pain. Over time, it assists in reducing leg cramping and discomfort associated with walking due to poor circulation. The tablet is part of a therapeutic approach aimed at improving walking ability and quality of life in patients with chronic arterial insufficiency.

Read More

About the Product

Cilospace 100 Tablet contains Cilostazol 100mg, a selective phosphodiesterase III inhibitor with antiplatelet and vasodilatory properties. It is primarily used to manage symptoms of intermittent claudication caused by peripheral arterial disease (PAD). Cilostazol works by inhibiting platelet aggregation and promoting vasodilation in the blood vessels, thereby enhancing blood flow, especially in the lower limbs. This improves oxygen delivery to muscles and helps patients walk longer distances without pain. Over time, it assists in reducing leg cramping and discomfort associated with walking due to poor circulation. The tablet is part of a therapeutic approach aimed at improving walking ability and quality of life in patients with chronic arterial insufficiency.

While generally well tolerated, Cilosize 100 Tablet may cause some side effects in certain individuals. The most commonly reported adverse effects include headache, palpitations, dizziness, and gastrointestinal disturbances such as diarrhea or abdominal discomfort. In rare cases, patients may experience chest pain, irregular heartbeat, or signs of bleeding. These side effects are typically mild and transient, but persistent or severe reactions should be promptly reported to a healthcare professional.

Cilospace 100 Tablet is indicated for the treatment of intermittent claudication, a condition characterized by pain or cramping in the legs during walking due to inadequate blood supply. It is used in patients with peripheral arterial disease to improve walking distance and reduce symptoms associated with impaired blood flow. The medicine is intended for individuals who do not respond adequately to lifestyle changes and exercise therapy alone. It may also be prescribed as supportive treatment in other vascular disorders, under medical supervision.

Cilospace 100 Tablet is contraindicated in patients with any degree of congestive heart failure due to an increased risk of cardiac complications. Caution is advised in individuals with a history of bleeding disorders, peptic ulcer disease, or those taking anticoagulant or antiplatelet medications. Liver or kidney impairment should be considered before initiating treatment. This medicine is not recommended during pregnancy or lactation unless specifically prescribed by a physician. Patients should undergo periodic monitoring to assess cardiovascular status and overall tolerance to therapy.

The tablet should be stored at a temperature not exceeding 25°C, in a cool and dry environment, protected from moisture and direct sunlight. It should be kept out of reach of children and not used beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation